Allschwil, Switzerland - INCATE, the Incubator for Antimicrobial Therapies in Europe, awarded Stage II funding to PhalconBio GmbH at its Selection Committee Meeting held virtually and at Basilea Pharmaceutica Ltd, Allschwil on September 1, 2026. [...]
More news
For the first time, INCATE’s Selection Committee didn’t simply meet — they came together in [...]
Obulytix has had an exciting start to the year, marked by important milestones and strengthening [...]
The 10th AMR Conference in Basel once again brought together some of the most passionate [...]
February 26, 2026— INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the [...]
The INCATE Selection Committee has selected five promising ventures to receive Stage I support. Want [...]
February 3, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting [...]
Every year, selecting the finalists for the Startup Pitch Event becomes more challenging, and 2026 [...]
January 21, 2026 – The Japan Pharmaceutical Manufacturers Association (JPMA) has joined forces with INCATE [...]
